ASIAN Hospital CyberKnife S7 media launch. PHOTOGRAPHS COURTESY OF ASIAN HOSPITAL
PARTNERSHIP

Asian Hospital offers new hope to cancer patients with country’s only CyberKnife

DT

A game-changer has arrived in the Philippines — the revolutionary CyberKnife S7, the first and only one of its kind in the country.

Now available to offer Filipino patients an innovative approach to cancer treatment, the CyberKnife S7 delivers unmatched precision, fewer sessions, and a non-invasive alternative to traditional radiation therapy.

The CyberKnife S7 System is the only radiation therapy machine that uses a robot to deliver high-energy rays while moving smoothly around the patient. This allows it to target the tumor from thousands of unique angles, making the treatment highly precise. By coming at the tumor from so many directions, it delivers the right dose exactly where it’s needed — while keeping the surrounding healthy tissue safe.

At the heart of CyberKnife’s breakthrough capabilities is its ability to track tumors in real time. Most conventional radiation therapy systems rely on static imaging, which means they can’t adapt to changes in a tumor’s position during treatment — especially problematic in areas like the lungs, where tumors move as the patient breathes.

Precise and Real-time Tumor Tracking
“This is the only machine that offers real-time tumor tracking during treatment,” said Dr. Jaemelyn Fernandez-Ramos, Cyberknife Expert at Asian Hospital’s Asian Cancer Institute. “It’s the highlight of this system — unlike traditional linear accelerators that take static images before treatment, CyberKnife S7 continues to monitor and follow the tumor during every second of radiation delivery.”

“And with the images taken during the treatment, there’s less damage to the healthy tissues around the cancer lesion,” Dr. Fernandez-Ramos added, noting that patients do not need to wear a harness and are allowed to breathe freely during the procedure.

Efficient Treatment
Due to its accuracy, CyberKnife S7 can safely deliver higher doses of radiation per session. That can mean fewer sessions overall and significantly shorter treatment times.

Depending on the patient’s treatment plan, CyberKnife sessions can reduce Lung cancer treatments from 30 sessions to just three; Prostate cancer treatments from 42 sessions to only five and Brain tumor treatments to as little as one session.

This not only minimizes the inconvenience and physical toll of daily hospital visits but also helps reduce the backlog of cancer patients awaiting treatment — especially important in a country like the Philippines, where cancer care resources remain limited.

“The burden of cancer in our country is high. By shortening treatment duration, CyberKnife S7 enables us to treat more patients effectively and efficiently,” said Dr. Enrico Tangco, Chief Radiation Oncologist at the Conquer C Center of the Asian Hospital’s Asian Cancer Institute.

CyberKnife S7

Painless Procedure
CyberKnife S7 is completely non-invasive, making it ideal even for patients who are not eligible for surgery, such as senior citizens with significant co-morbidities. It reduces exposure to healthy tissue, minimizes side effects, and improves overall comfort.

With no incisions, nil anesthesia, and low recovery time, patients can return to their daily lives more quickly — and with better outcomes.

The machine is also pediatric-friendly, designed to treat children with minimal discomfort and maximum precision.

Step Forward
“The year 2025 is another transformative year for Asian Hospital and Medical Center. We are set to enhance and expand our services with several key developments — one of which is the acquisition and launch of the very first CyberKnife in the country,” said Dr. Beaver Tamesis, President and CEO of Asian Hospital Inc.

“This is part and parcel of our commitment to excellence and community service. We recognize that progress is not just about keeping pace. It’s about accelerating toward something greater. It is about constantly innovating, improving, and challenging ourselves to do more and be more for the people who rely on us.” he added.

This sentiment was echoed by Dr. Carmen Nievera, Chief Medical Officer of Asian Hospital, who emphasized that the acquisition of the CyberKnife S7 is part of Asian Hospital’s commitment to continuous innovation and improved service.

“We must accelerate with purpose. The future of healthcare is not something we wait for — it is something we create together,” Dr. Nievera added.

For her part, Dr. Corazon Ngelangel, Program Director of the Asian Cancer Institute, said that the CyberKnife S7 is a testament to the hospital’s commitment to innovation and patient-centered care.

“As we navigate challenges, we embrace opportunities that propel us forward — pushing boundaries, redefining standards, and strengthening our resolve to deliver world-class healthcare for all,” she said.

With its unparalleled precision, real-time imaging, efficient treatment delivery, and painless, non-invasive approach, the CyberKnife® S7 represents a major leap forward in cancer care in the Philippines.

As the only system of its kind in the country, it is set to transform lives — offering patients new hope, better outcomes, and a more compassionate path to healing.

For inquiries, call the Asian Hospital and Medical Center hotline at 8-771-9000 local 8105 or send us an email at aci@asianhospital.com. Follow Asian Hospital social media pages for up-to-date information at //AsianHospitalPH.